The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Antihistamine use may improve oncologic and survival outcomes in patients receiving second-line atezolizumab for advanced or metastatic urothelial carcinoma, according to research published in ...

Researchers found that, in patients with stage III NSCLC, treatment with cCRT and an ICI was safe, but treatment with cCRT and 2 ICIs led to “excessive mortality.” ...

In a survey, less than half of cancer patients and their family members said they were willing to participate in a clinical trial, and about a third of respondents said they had a positive perception ...

The improvement in the well-being of fellows over the past decade likely stems from intentional changes to training programs,” researchers wrote.

The cost of caring for a Medicare patient far outpaces the reimbursement that physicians receive for seeing them,” said Congressman Greg Murphy, MD (R-NC).

The new Trump administration has begun taking down government websites, including many pages that include DEI initiatives.

Burnout in US oncologists has increased over the past 10 years, according to results of 2 surveys. 1 Researchers compared results of a 2023 survey of 328 oncologists to results of a 2013 survey of ...

DNA testing may inform treatment decisions and predict outcomes of adjuvant chemotherapy in patients with stage II-III colorectal cancer.

An investigational blood test can detect colorectal cancer (CRC) in patients at average risk of CRC, a study suggests.

(HealthDay News) — Staff at the US Centers for Disease Control and Prevention (CDC) have been told to stop communication with the World Health Organization (WHO) in the wake of President Donald ...